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The Original

John P. McGovern, M.D. 1921 - 2007
When I became Dean of GSBS mid 1999, I did not
know Dr. McGovern, but knew of his serious commitment
to biomedical research and education long before then.
He was a great supporter of education at the Graduate
School, e.g., McGovern Teaching Awards and McGovern
Poster Awards, and an equally strong supporter of research
at many institutions in the Texas Medical Center. I knew
of his clinical acumen since my wife was a patient at his
al lergy clinic and was a great admirer of his before we ever
met.
Early in 20011 received a phone call from Dr. McGovern's office asking
if I would meet with him at his home. When I arrived he was cordial and we
exchanged brief pleasantries- he then said very nonchalantly, "We can keep on
throwing posies at each other, or you can tell me what your school needs." 1
responded that we had one overriding need - to recruit and support outstanding
and capable students from a variety of backgrounds. He asked how he could help.
He wanted to honor me with a professorship. Together we strategized how the
first endowed professorship in the biomedical sciences would be held by me and
each succeeding dean at GSBS with the income targeted ro provide student recruitment funds and scholarships for what would best achieve that goal. He
asked where to send the check, and I was immediately certain that he had done a
great deal of homework about our School (and perhaps its new Dean !) long before I walked through his door that afternoon.

I made it a point to send him notes in subsequent years thanking him for
his support, sometimes with pictures of the students who benefited from the endowment income, and every year he sent a gift to add to the endowment. Supporting students and their research training was a never-ending process for Dr.
McGovern throughout his life and will remain as his legacy at GSBS.
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Benefactor

George Stancel, Ph.D.
Dr. John P. McGovern was the first and continuously generous financial donor to the Graduate School of Biomedical Sciences. I had contact with
him almost from the first day I walked in the door of the GSBS in 1966. He was
also my allergist. He was the quintessential Southern Gentleman and was committed to personally preserving the "History of Medicine." The GSBS bestowed
the title of Professor of the History of Medicine to him which he often listed
among his credits. He was a major force in overseeing the preservation of appropriate books and documents detailing how medical training and practice evolved.

l had many and always positive contacts with him over the years. He
always signed his formal letters to me (usually when he sent in his annual donation) "Jack."
'

I always addressed him in correspondence and called him "Dr.
McGovern." In the many articles written about him in the newspapers following
his death, one said that he always insisted that his friends call him "Jack." That
pleased me more than I can express in this tribute.

Melva Ramsay

an's
otes
Candidacy and Time to Degree Is Less More?
On the way to achieving a
Ph.D. in the biomedical sciences we
train our students in critical thinking and sharpen their intellectual
prowess as they study and develop
research projects for the ultimate
purpose of making new key discoveries. Most in my generation received our Ph.D.'s in 4-5 years, often closer to four. At GSBS that
figure is now approximately 5 'l2
years on average and eve n approaching 6 for certain programs.
This is well below the na tio nal
norm (7 years o r more for biological sciences depending upon whose
statistics you use and the specific
discipline). Even so, it is in
everyone's best interests to ask
whether it can be decreased without sacrificing the quality of the students' education.
If we consider the two main
phases of doctoral training, pre- and
post-candidacy, there arc things we
might do in both. Better mentoring,
increasing expectations of faculty
(with commensurate recognition),
and more clearly defined expectations for faculty and students wou ld
help in both phases, but the time
spent in the post-candidacy phase
is likely to remain the more variable and difficult to prescribe. On
the other hand, are there other
things we might do to decrease the
time it takes studen ts to progress to
candidacy, i.e., to be ready to undertake independent dissertation
research?

A place to start might be
the primary purpose of the candidacy exam. If the goal is to assess
whether a student is capable of undertaking independent research and
ready to do so, is it necessary for
the student to genera te a large
amount of data for their exam proposal? If we used options such as
writing a proposal on a topic other
than one's own research or reducing the amount of preliminary data
(real or perceived) that students and
mentors think they need, could we
mandate a shorter, invariant amount
of time such as two years to pass the
candidacy exam. We should always
allow exceptions for reasons such as
entrance deficiencies, health problems, etc., but the real question is
whether two years is sufficient for
most students if we have proper
admission's criteria? These is not a
simple issue, but the point is to
think about how we might shorten
the time to candidacy so that qualified students could begin the dissertation project sooner and the few
who were not, or became interested
in other things, could consider realistic options rather than spending
more unproductive time in a Ph.D.
program. This would a llow everyone more time after GSBS to make
contributions to society which is the
ultimate goal.
Another issue(s) is how effectively we prepare students to advance to candidacy in their first two
years at GSBS. Could we do more

in the tutorials to identify the needs
of individual students and he lp
them learn the skills we wish to test
in the candidacy exam? Should advisory committees meet more often
in the second year to guide students
more efficiently and effectively?
Can we use advisory committee
meetings to focus more explicitly on
students' intellectual progress and
critical thinking skills rather than
emphasizing the preliminary results
he/she has generated and suggesting new experiments? Should we
encou rage capable students with
entrance deficiencies to begin their
GSBS educations in the summer
rather than the fal l term of their first
year? Are there other creative
things we can do?
This is a major academic
issue, and whatever we do should
be faculty driven and invite student
comment. I would like a ll of us to
take a fresh look at this issue and I
encourage Programs and individual
facu lty to give it so me serious
thought; we would all benefit in the
long run if we could reduce time to
degree -- less might really be more
at GSBS.
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2006-2007 GRADUATES MASTER OF SCIENCE DEGREE
Atkins, Krista! (Nacbum Dafny, Ph.D.)
Behavioral and neurophysiological mechanisms underlying psychostimulants
C urtis, Leigh (Roger Janz, Ph.D.)
The role of syntax in 3B in retinal ribbon synapses
Defant, J ennifer (Alex Vidaeff, M.D.)
Preeclampsia and the trisomy 21 conceptus
Greenberg, Brandon (Guillermina Lozano, Ph.D.)
The role of mutant p53 in metastasis
G rove, Megan (Eric Boerwinkle, Ph.D.)
Gene environment interaction in the atherosclerosis risk and communities project (ARIC)
Huynh, Ly (Thomas Goka, Ph.D.)
Cysteine-switch control of the Ras/Raf/MEKIERK pathway in COS-7 and breast cancer cells
Kline, Keith (David Eagleman, Ph.D.)
Why is the perceived direction of motion sometimes opposite the actual direction
Knisley, Alyssa (J ennifer Hoskovec, M.S.)
Maternal serum screening: docs the frequency of abnormal results vary with ethnicity
Lin, P ei-C hun (Xin Lin, Ph.D.)
The molecular mechanism of G-protcin-coupled-rcccptor-mediatcd NF-kappaB activation
Merritt, William (Menashe Bar-Eli, Ph.D.)
Effects of targeting lL-8 on ovarian cancer
l'iica, Alina (Peter Ru volo, Ph.D.)
Ceramidc induces cell death in chronic myeloid leukemia-derived K562 cells by a caspase-8-dependcnt
apoptotic mechanism
Patel, Purvi (Yong-Jian Geng, M.O./Ph.D.)
The role of gclsolin and signal transducers and activators of transcription 3 (STAT3) in vascular smooth muscle
cell iNOS expression
Sa lo, Erin (Miguel Rodriguez-Bigas, M.D.)
Survey of the cancers and genotype-phenotype correlations in the HNPCC patient population at
UT M.D. Anderson Cancer Center
Stanford, Amy (Sarah Noblin, M.S.)
Expanded newborn screening in Texas: a survey and educational module addressing the knowledge of pediatric residents
Stetson, Robert C hess (David Eagleman, Ph.D.)
Plasticity and neural correlates of time perception
Sullivan, Cathy (Terri IGng, Ph.D.)
The impact of genes in glucose metabolism on rostral lesion location in patients with spina bifida meningomyelocele
Tipps, Catherine (Jacqueline Hecht, Ph.D.)
Trisomy 21, 18, and 13 in Texas: prevalence and mortality study
Tseng, Jui-chuan (William Plunkett, Ph.D.)
Cellular and molecular pharmacology of the S-phase checkpoint pathway: a mechanism for cell survival
Uffort, Ocon (Julie Ellerhorst, .M.D.!Ph.D.)
The regulation of the inducible nitric oxide synthase via the mitogen-activated protein kinase pathway through
NF-kappaB activity
Zhao, Ruiying (Mong-Hong Lee, Ph.D.)
The COP9 signalosome subunit 6 (CSN6) is essential for early embryonic development in mice

GRADUATion CELEBration

Carter, J ennlter (Subrata Sen, l'h.U.)
High-resolution microarray analyses of chromosome 20q amp Iicon in human colon cancer metastasis model systems
C hang, Yao-Fu (Miles Wilkinson, Ph.D.)
T-cell receptor nonsense-associated altered splicing
C hen, C hih-llsin (Richard Behringer, Ph.D.)
Comparative studies of Hox genes in mammalian limb and vertebral pattern formation
Childre , J ennifer (Georg Halder, Ph.D.)
Lethal giant discs, a novel C2 domain protein restricts notch activation during endocytosis
C hunn, Janci (:\'lichacl Blackburn, Ph.D.)
Adenosine induced pulmonary fibrosis and the contribution of the adenosine A2B receptor to the induction of osteopontin
in a mouse model of pulmonary fibrosis
Dembinski, J ennifer (Michael A ndreeff, M.D./Ph.D.)
Examination of the engraftment of exogenous mesenchymal stem cells in ovarian tumors and their potential use as delivery
vehicles for therapeutic genes
Den Hollander, Petra (Rakesh Kumar, Ph.D.)
Nuclear functions of dynein light chain I in hormone action
Edwards, Sharon (Richard Sinden, Ph.D.)
Non 8 -D A structures and genetic instability associated with myotonic dystrophy type 2 (CCTG).(CAGG) repeats
Fu, Xueyao (William Klein, Ph.D.)
Mouse retinal development: role of cell adhesion and mechanism of gene regulation
Hadjifrangiskou, Marla (Theresa Koehler, Ph.D.)
Cis-acting elements and developmental regulators govern toxin gene expression in Bacillus Anthracis
H awthorne, Valerie (Dihua Yu, M.DJ Ph.D.)
Transcriptional upregulation of the p2 1cipl promoter by STAT3 and nuclear ERBB2
Imam, Jaafer (Miles Wilkinson, Ph.D.)
Regulation of R A splicing by nonsense mutations
Johnson, A mber (Michelle Barton, Ph.D.)
Hypoxia-induced transcriptional regulation through chromatin modifications and NC2 function
Koch, icholas (Wayne ~ewhauser, Ph.D.)
Monte Carlo and analytical dose calculations for ocular proton therapy
Kry, tephen (Mohammad alehpoor, Ph.D.)
The development and validation of a Monte Carlo model for calculating the out-of-field dose from radiotherapy treatments
Leduc, Magalie (J ames Hixson, Ph.D.)
Identification of genetic variation influencing apoE levels: follow-up of genome scans in GENOA
Lin, Wenchu (Sharon Dent, Ph.D.)
Requirement of GCN5 histone acetyl transferase in mouse neural tube closure and skeletal patterning
Lyons, J on (Pierre McC rea, Ph.D.)
Analysis ofWNT/beta-catcnin signaling in kidney tubulogcncsis
Mak, Solida (James llixson, Ph.D.)
Expression study of atherosclerotic mouse ao rta revealed significant disturbance of calcium signaling pathway
Marks, Hilnry (Sara Peleg, Ph.D.)
New insights into the role of the duodenal vitamin D receptor in calcium homeostasis
Marsh, Rebecca (J ohn Hazle, Ph.D.)
Measuring treatment response in irradiated murine tumors with diffusion-weighted magnetic resonance imaging
Mashruwala, Mary Anne (Chinnaswamy Jagannath, Ph.D.)
Regulation ofT cell function by compliment C5a in mice during mycobacterial infection
Meng, Qingchang (Rakesh Kumar, Ph.D.)
Regulation of Poly-C-RNA binding protein I functions by PAKI signaling

COMMENCEMENT 2007

ADDRESS

Robert D.Wells, Ph. D.
Professor &Director
Center for Genome Research
Texas A&M University System Health Sciences Center
Institute of BiosciencesandTechnology

"The Scientist Citizen"
It's a wonderful day. Congratulations to all of you. I
think it's fantastic. You've gotten your degree, and now
you're off to other things. I'd like to say just a few words
about what some of those other things might be.
Keep in mind that change will occur in your lives. Welcome change. Embrace it. You will have three or four or
five different careers in your lives. Don't be intimidated by
that. In fact, to the contrary, as I say, embrace it and move
forward. I think it's wonderful.
What's going to happen in your lifetime, scientifically?
Well, I don't know that, and I don't know that any of you
know that; but l can tell you something about what's happened in my lifetime. I started graduate school in 1960, got
my Ph.D. in '64 and as Dr. Stance! has said, I did a post-doc
from '64 to '66.
But what's happened in my lifetime? Let me just run
down a list of some developments l think all of you know
about, but you take for granted today. First of all, amino
acid analyses of proteins. That came into ex istence when I
was a graduate student, the Moore and Stein analyzers.
Protein sequencing came into existence when I was a
graduate student. The sequence of the first protein, insulin;
the second, the coat protein of tobacco mosaic virus; the
third, ribonuclease. We take protein sequences for granted
today, but it was not always that way.
Peptide synthesis came into existence in those days, and
today we can chemica lly synthesize almost any molecule.
That's phenomenal. When I started graduate school, that
was o ut of the question. There were lots and lots of mo lecules like Vitamin B-12, etc., which were beyond the capability of chemical synthesis.
Dr. Stance! mentioned the genetic code. That just fell
out at our feet . It was the brilliance of Marshall Nirenberg
and Gobind Khorana; because they developed the appropriate methodologies, the experimental results that solved
this mystery, were obtained in about 18 months. And that
code is the basis of virtually every grant proposal that goes
through the N ational Institutes of Healrh today.
We know, 1 would estimate, 90%, to 95% of all of the
molecules in a cell. When l started graduate school, when I
was in your shoes, there was no way we had that kind of
knowledge.
Cancer as a suitable ropic for serious research endeavors has come into existence in my lifetime. The entire field
of neurobiology has come from nothing. Restriction enzymology and gene cloning didn't come into existence until
the mid to the late 1970s. Eucaryotic genetics and molecular biology came into their own. When 1 was in your shoes,
we could only study procaryotes; there were really only very
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sparse studies that were going on in eucaryotic systems.
The biotechno logy industry flourished in the 1970s.
When I was in your shoes, there were half a dozen or so
companies that were selling what was basically reagents to
the researcher. Today we have hundreds of biotech companies. That's also meant another change in the world, and
that is that a number of scient ists have become wealthy.
This also has been a major change because when I started
my own laboratory, a number of scientists I could see around
me were very comfortable, but they certainly weren' t
wealthy. But that has now changed.
The use of diverse cells and organisms has certainly created a tremendous change in our science. The sequence of
genomes, starting with the human genome but now scores
of other genomes, is really very important and has given rise
to the field of genomics.
1 never dreamed, when I got my Ph.D. degree, that I
would see another pandemic. l am old enough to remember
polio and the polio issues when I was a teenager. But today
we have AIDS, we have obesity, and we have diabetes. And
so there are many challenges that are out there in front of
you.
Xerox machines have altered science. It's true. When
I was a graduate student, there was no such thing as a Xerox
machine. And 1 invited - that's a nice word to use - I invited my wife, Dotty, to come tO the library with me on
several evenings and to copy down methodologies that I
needed for the next day's experiments because there was no
way to duplicate it. But in fact we take this for granted
today. And of course the Internet searches for scientific
papers have really made the search of the scientific literature much, much more easy.
So what's going to happen in your lifetime? Well, I
don't have a crysta l ball, and I can't tell you the specifics.
But in general, it's going to be the investigation of the spatial and the temporal interrelationships between these molecules that we know exist in a cell. In other words, how do
you put it all together, and what is the wiring diagram?
Let me tell you a small side story, and that is that I gave
an endowed lecture at the M. 0. Anderson Cancer Center
in Smithville within the past year. A young faculty member had some background on me such as Dr. Stance! has just
reviewed. He said, "Oh, Or. Wells, you've done such great
things in your life. Your generation has solved virtually all
of the important problems in biology." I told him at that
point that I didn't believe that for a second. In fact, quite to
the contrary, I think it is your generation that has the opportunity to reach out and to make much more profound
discoveries than, in fact, in the previous generation.

Why do people do science? Why are you sitting here?
Why have you worked so hard to get your Ph.D. degree? I
think there are fundamentally three reasons wh y people go
into science, or some mixture of these reasons. Number
one is altruistic, namely, to contribute knowledge, and that's
very important. The second reason is money. You know
that there is a chance that you will have a comfortable
lifestyle. I think that's very important, and I think we ought
to talk about that sort of thing. But the third reason is curiosity. There are some of you who could not do anything
else. You were driven to learn a science. So I think there
are basically those three reasons why people get into science.
Now let me say a few words more to add to Dr. Dent's
remarks regarding responsibilities. As a scientist, you have
a responsibility to be a good citizen. What does that mean ?
W ell, you must define that, and it will change in your lifetime. But, number one, I would say, this means you must
vote. Very simple . Vote. Stand up for the individuals chat
you think are going to do the right thing for society and also
for medica l research and for science.
Second, speak out on the issues. Do not keep quiet.
Look at what's going on with evolution today in this country. Look at what's going on with a wide range of other
issues. And legislators, members of Congress, do not know
what's going on in science. They rely on you. You've got to
tell them. So get invo lved with your congressmen, either in
your home district or in Washington. Next, advise the general population. Get involved with c ivic groups. Get involved in church groups. Get involved in any sort of organization where you have the privilege of talking with people
and expressing your views concerning the funding for medical research.
Yes, we were successful in getting the budget for the
NIH doubled from 1999 to 2004, but due to a very hard
landing, we find ourselves in a situation where it is much
harder for scientists to get funded today. And so we've got
to interact with and influence Congress to inform them of
the needs of the medical research community. They don't
know this a priori. In fact, only a few percent of everybody
in the United States, less than ten percent of all people in
the United States, know what federal agency funds medical
research. Let me repeat that. It's less than ten percent of
the general public who can tell you that it is N IH, N ational
Institutes of Health, that funds medical research.
A lternatively, Research A merica, an organization in
Washington, has taken another poll to ask the question,
"How important do you think medical and health research
is to the U.S. economy:" 94% said important, 4% not important, and 2% said they didn't know. Hence, the American public does support medical research, but they don't
know very much about it; so you've got to get involved.
In addition, jo in your scientific societies. If you're a microbiologist, that's ASM, A merican Society for Microbiology.
If you're a biochemist, that's AS BMB, American Society
for Biochemistry and Molecular Bio logy; cell biology is the
American Society for Cell Biology. These are the organization that work together as a group of scientists to, in fact,
try to effect change in Washington. And so my message
regard ing science and your citizenship is, get involved.
Your road in the future may not always be easy. You
know that. And you may need to persevere. Perseverance
has certainly been a hallmark in my life. In my research
programs, we have worked for 38 years to discover new types
of non-B-DN A structures, such as cruciforms, slipped struc-

tures, bent DNA, etc.; however, it has taken all of this time
to understand the biological functions of these structures.
But it's only about two years ago that, in fact, we learned
that these structures arc at break points for gross deletions,
rearrangements, etc., that cause some 70 human d iseases.
So, I have worked for roughly 38 years to lay the background
but it has only been within the past couple years that we
have really d iscovered the medical implications of these dis·
coveries.
Therefore, you need to persevere in your activities.
Thinking of perseverance always reminds me of a wonderful, h umorous story about the penguin and the bar. T he
penguin went into a bar one day and asked the bartender,
"Do you have any grapes?" T he bartender says, "No." T he
penguin walks out. The second day, the penguin walks back
into the bar and asks the question, "Got an y grapes?" T he
bartender says, "N o. And I hope you'll get out of here."
The penguin walked out. The third day, the penguin walks
back into the bar, asks the bartender, "Got any grapes?" The
bartender says, "No, and get out of here because if you don't,
if you come back again, I'm going to nail your webbed feet
to the floor." Fourth day. W hat happens? The penguin
walks back into the bar and says to the bartender, "You got
any nails?" The bartender says, "No." The penguin says,
"Got any grapes?"
So persevere in your endeavors. Have great fun. And
congratulations.

John P. McGovern Outstanding Teaching Award
The

annual

John

P.

McGovern Outstanding Teacher
award winners are nominated and
elected by the student body based
on a number of criteria which in clude: excellent and enthusiastic
teaching, the ability to stimulate and
encourage independent thinking,
responsiveness to student questions,
and finally, a commitment to, and
passion for, student academic and professional development. The winner of this year's award, Dr. Kevin
Morano, demonstrates all of these qualities.
As a researcher, Dr. Morano is well known in
his field of Microbiology and Molecular Genetics for his
excellent work, and has won a number of research awards
to commemorate this.
Dr. Morano is an excellent scientist, dedicated
to adding quality work into the body of knowledge of h is
field and he sets an example that demonstrates how basic research can be useful for cll!ing d iseases and saving
lives. He supports the studen t body in everything that
he does- from mentoring students to teaching classes to
actively participating in the GSBS. He is devoted to
the students ana works hard to help us develop as independent thinkers and as scient ists. Dr. Morano motivates
those around him to achieve excellence by his act ions
and his words • he embodies the concept of an outstanding teacher.
-Pat Gibney, Graduate Student Associati<m president, 2006-2007
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COMMENCEMENT GREETINGS
from the GSBS Faculty President
Sharon Roth Dent, Ph.D.
GSBS Faculty President, 2006-2007
I am so very happy and honored to welcome you all here today. I congratulate each of you, along with your families, loved ones, and mentors who have
stood behind you on this quest, on the completion of your degree.
I have been a faculty member here since 1993, so I have heard many excellent and inspiring speeches from my esteemed
colleagues on graduation day. l think one of my favorites was by Or. Kripke, when she was President of the graduate
faculty. She began by assuring everyone that she would not take too long, because she knew that most people are roo
excited on occasions like this to remember what the speakers say, but they almost always remember how Long it took them
to say it. I too will strive to be concise.
When I graduated with my Ph.D. back in mid 1980s, my degree was actually printed on a sheepskin, so it took
awhile to prepare. As we walked across the graduation stage, we did not get a diploma. Instead we got a rolled up p1ece
of paper, which likely told us when and where to go pick up our actual diplomas.
I, like you, was feeling very proud and I was so looking forward to moving on to the n ext stage of life. So I did not
mind that I had to wait for the diploma to be ready. No more qualifying exams; no more meetings with my committee; I
was done!! When I actually got my degree a few weeks later and read through it, I was pleased to sec that they had spelled
my name right and thrilled that it said I had a PhD. However, I w-as a little taken aback by the last line, which read " ... all
the rights, duties, and privileges appertaining to that degree." I was ready for new rights, and I was already expecting some
new privileges. In fact, I had already begun a post doc and I was enjoying very much n o longer having to struggle by on a
student's salary. But what was this stuff about duties?? 1guess that was the first time that I realized that a higher degree is
not just a stepping stone; it is a lifelong title that reflects expectations that others now have of you.
So I ask you, are you ready for your duties as a scientist? What do you think these duties are? You arc probably
thinking, well that depends on what kind of job I get, on what my boss wants me to do, on what my spouse wants me to do.
But I am talking about fundamenral duties that come with higher learning. Although there are numero us such duties we
could discu today, I want to focus on just three.
The fi rst and foremost duty, in my mind, of a scientist is to uphold the highe t standards of excellence and integrity-- in
your science, in your teaching, and in your life.
Aristotle said,

"Excellence is an art won by training and habituation. We do not act righrly because we have virtue or excellence, hut we rather have those because we have acted rightly. We are what we repeatedly do. Excellence, then ,
is not an act hut a habit."
It is our duty to make excellence our habit.
The second duty we have is co make a difference, to use our learning to push the envelop whenever po ible. This
duty will require some courage, a lot of dedication , and it may involve some risk. But to paraphra e David Lloyd George
(a WW I era British statesman), "Don't be afraid to take a big leap; you can't cross a chasm in two small jumps."
However, that is not to say that small steps arc not important. Sometimes the biggest advances come from a series of
painstaking studies. just make sure that even your small steps are strong ones that will move you in a forward direction.
Never stop learning and always stri ve for significance.
Our third duty, I think, is to 'pay it forward'. All of us got to this point in our live and our careers with support
and guidance from family, mentors, teachers, even committee members. You may not ever be able to pay everyone back
for that support, but you can pass it on to future generations of young scientists, or to anyone who i eager to learn. I urge
you to give freely of yourself. You'll be surprised how often such giving enriches your own life.
I'll end with a quote from T om Brokaw, which must have been i ued at a commencement exercise much like this
one. He said,
"You are educated. Your certification is in )'Our degree . You may think of it as rhe ticket 10 the good life. Let me
ask you to think of an alternative. Think of it as your ticker to change the world."
O n behalf of all the faculty: Congratulations, good luck, and stay in couch!
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Faculty honors
Michelle Barton, Ph.D. noted that the
Genes and Development program
received a $250,000 gift fi·om the
Wil liam Randolph Hearst Foundation
through the efforts ofUT M.D.
Anderson development office and will
provide for two graduate student
stipends each year and two faculty
"seed" grants for innovative research
involving graduate student trainees.
Robert C hamberlain, Ph.D. was
awarded the Margaret Hay Edwards
Acb.ievement meda l presented by the
American Association of Cancer
Education.
Robin Fuchs-Young, Ph.D. has
received a five-year $750,000 grant
fi·om the Howard Hughes Medical
Institute for a new education program
to "open mi11ds to health, science and
careers."
J acqueline Hech t, found ing director
of the GSBS Generic Counseling
program, received the 2007 Barbara
Bowman Djstinguished Texas
Geneticist Award from the Texas
Genetics Society.
Mien-Chie H ung, Ph.D., Robert
C hamberla in, Ph.D., E mil F r eireich,
M.D., Michael Ahearn, Ph.D. and
Stephen Tomasovic, Ph.D. were
recommended for an award of The
University ofTexas System title of
Distinguished Teaching Professor.
E dward Jackson, Ph.D. ( 1990/
Naryana) is Pl for the first Medical
Physics NiH T-32 Training grant
totalling $1.9 Mover five years.

E ugenie KJeinerman, M.D. was
honored with the 2006 Duke University Distinguished Medical Alumni
Award.
Cheng Chi Lee, Ph.D. wins NlH
Director's Pioneer Award, $2.5M over
five years to further his research.
Steven Norris, Ph.D. was a recipient
ofthe inaugural UT Chancellor's
Entrepreneurship and rnnovation
Award for his research in the development of a Lyme Disease test. Two
graduate students involved in the
research were J ing-Ren Zhang and
Matthew Lawrenz. Jing is now an
assistant professor at Albany Merucal
College, and Matt is a postdoctoral
fellow at Washington University
School ofMedicine in St. Louis.
Hope NortbJ·up, M.D. opens the
region's first clinic at Memorial
Hermann l-lospital dedicated to the
diagnosis and treatment of Tuberous
Sclerosis Complex (TSC).
Stanley Schultz, M.D. Teceived the
Prince Mahidol Award for Medicine
in Taiwan for his contributions to the
rationale that led to the development
of oral rehydration therapy.
J ohn Spudich, Ph.D. was elected a
Pellow of the American Academy of
Arts and Sciences.
H einrich Taegtmeyer , M.D.,D.of Ph.
was elected president of the International Society for Heart and Vascular
Metabolism.

Xinping Zhao, Ph.D. received the
24th Biennial Cornea Research
Conference Conm1itteeAward.
UT M. D. Anderson F acnlty Schola r
Awards: Mark Bedford, Ph.D., Peng
Huang, M.D., Ph.D.,ALtil Sood,
M.D.; Faculty Achievement Awards:
Cheryl Walker, Ph.D., John
DiGiova1tni, Ph.D., Pierre McCrea.
Ph.D.
UT H ealth Science Cen te1·
President's Scholar Award for
ExceUence in R esear ch : Ponnada
Narayana, Ph.D., Ferid Murad, M.D.,
Ph.D.; President's Scholar Award for
ExceiJence in Teaching: Henry
Strobel. Ph.D. Young Investigators
noted: Kevin Morano, Ph.D.. Ambro
van Hoof, Ph.D., Blanca Restrepo,
Ph.D., Peter Ruvolo.
D eparting Faculty:
Bruce Kone, M.D., Ph.D. to become
Dean of the University ofFlorida
College ofMedicine.
Kenneth W u, M.D., Ph.D. to begin a
new position as president and distinguished investigator of the National
Health Research Institutes in Taiwan.
Stanley Reiser , Ph.D. an internationally known scholar and pioneer in
ethics, and longtime (1983-2007) cocreator of the GSBS course The
Ethical Dimensions in the Biomedical
Sciences starts a new position at The
George Washington University.

G SBS Faculty Membership Report
Members Reappointed with
Highest Commendation

Sharon Dent
Ruth Heidelberger
Diane Hickson, Bick
Edward 1ackson
Ralf Krahe
Richard Kulmacz
Guillermina Lozano
Pierre McCrea
1agannadha Sastry
Heinrich T aegtmeyer
Dihua Yu
Members Reappointed
With Commendation

Phillip Carpenter
Stephen Daiger
Carmen Dessauer
David Followill
1acqueline Hecht
Peng Huang
Yuan 1i
1ian Kuang
William Margolin
David McConkey
Emeritus
Member Appointed

Harry Sperling
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Retiring in August (except for
special projects) faculty member,
and long a valuable resource for
edu cation, Margaret Kripke,
Ph.D., Executive Vice President
and Chief Academic Officer at
M.D. Anderson Cancer Center
is presented with an aerial view
of the Texas Medical Center and
a silver bracelet inscribed with
her years of service to GSBS:

1983-2007

NEW
Regular Members
Christian R. Abee
Doctor, R. Lee C lark Professor and Chair
Veterinary Sciences
M. D. Anderson Cancer Center
D.V.M., Texas A & M University, 1971
Research interests: nonhuman primate disease models; primate reproductive biology;
assisted reproductive technologies
Jonas S. Almeida
Professor
Biostatistics and Applied Mathematics
M. D. Anderson Cancer Center
Ph .D., University of Lisbon, 1995
Research interests: systems biology;
biomarker identification; drug/target discovery; statistical mechanics
Banu Arun
Associate Professor
Breast Medical Oncology/
C linical Cancer Prevention
M. D. Anderson Cancer Center
M.D., University of Istanbul, l990
Research interests: breast cancer risk assessment; identification of risk markers, surrogate biomarkers and novel preventive and
treatment agents
E. Neely Atkinson
Professor
Biostatistics and Applied Mathematics
M. D. Anderson Cancer Center
Ph.D., Rice University, 1981

Research interests: optical methods for early
detection of cancer; design and analysis of
clinical trials; modeling of dose-response
curves and surfaces
Gabor Bahizsi
Assistant Professor
Molecular Therapeutics
M. D. Anderson Cancer Center
Ph.D., University of Missouri - Sr. Louis and
Rolla, 2001
Research interests: mathematical/computational modeling and experimental characterization of biomolecular interaction networks
Richard G. Brennan
Professor and Robert A. Welch D istin<>uished University Chair in Chemistry
Biochemistry and Molecular Biology
M. D. Anderson Cancer Center
Ph.D., University of Wisconsin - Madison,

1984
Research interests: multidrug resis tance,
protein-nucleic interaction, regulation of
gene expression; oxidative stress responses;
protein-ligand interaction, toxin-antitoxin
structure and function; macromolecular
crystallography
Claudio N. Cavasotto
Assistant Professor
UT-H School of Health Information
Sciences
Ph.D., University of Buenos Aires, L999
Research interests: computational chemis-

try; compU[ational biology; ligand-based and
structure-based drug discovery; proteinligand and protein-protein interaction;
force-field development; cheminfonnatics
Shine Chang
Associate Professor, Epidemiology
M. D. Anderson Cancer Center
Ph.D., University of North Carolina at
Chapel Hill, 1995
Research interests: cancer prevention and
control; biobehavioral determinants of obesity; epidemiology; health science research
training and evaluation; career development programming and professional education
Laurence J. N. Cooper:
Associate Professor, Pediatrics
M. D. Anderson Cancer Center
Ph.D., Case Western Reserve University,
1993
M.D., Case Western Reserve University,
1994
Research interests: immunotherapy; T-cell
therapy; gene therapy; hematopoietic stemcell transplantation; bone marrow transplantation; development of immunological
approaches to treat pathogens and malignancies; pediatrics
Brian R. Davis
Associate Professor
Ce11Lre fur SLeut Cell Re:;t::ardt

UT-H Institute of Molecular Medicine
Ph.D., California Institute of Technology,
1980
Research interests: gene editing of stem
cells; stem cell biology; gene therapy; hematopoietic stem cells; somatic reversion;
molecular genetics
John F. de G root
Assistant Professor, Neuro-Oncology
M. D. Anderson Cancer Center
M.D., UT Medical Branch at Galveston,
1998
Research interests: role of glutamate transporters and receptors in the regulation of
growth and progression of human glial neoplasms; regulatory loops in human gliomas
and their effects on cellular proliferation
and migration
Mauro Ferrari
Professor and Director, NanoMedicine
UT-H Institute of Molecular Medicine
Ph.D., Universiry of California, Berkeley,
1989
Research
interests:
biomedical
nanotechnology; translational science;
medical therapeutics in drug delivery application in oncology, cardiovascular disease and diabetes; biosensors and
biosepar.ation technology; multiscale discrete/continuum mechanics and

biomechanics
Michael T. Gillin
Professor/Deputy Chair and Chief
Radiation Physics/Clinical Services
M. D. Anderson Cancer Center
Ph.D., University of California at
Davis, 1970
Research interests: clinical application of
protons; clinical trials; infonnation management; calibration of radiation beams
Vidya Gopalakrishnan
Assistant Professor, Pediatrics
M.D. Anderson Cancer Center
Ph.D., University of Pittsburgh School of
Medicine, 1995
Research interests: pediatric brain tumors;
identification of novel therapeutic targets;
regulation of transcription factors in brain
tumors and normal brain development
Barrett R. H arvey
Assistant Professor
UT-Houston
lnstitU[e of Molecular Medicine
Ph.D., Universiry of Texas at Austin, 2003
Research interests: applied biologics; recombinant antibodies; directed evolution; high
throughput selections
H amed Jafar-Nejad
Assistant Professor
UT-H Institute of Molecular Medicine
M.D., Tehran University of Medical
Sciences, 1994
Research interests: cell biological regulation
of signaling pathways; neuronal precursor
specification and differentiation; intracellular trafficking; asymmetric division; sugar
modification of signaling proteins
Valen E. Johnson
Professor
Biostatistics and Applied Mathematics
M. D. Anderson Cancer Center
Ph.D.• The University of Chicago, 1989
Research interests: Bayesian analysis with
a focus on Bayesian model diagnostics and
testing; ordinal and categorical analysis;
model selection and Bayesian model averaging; statistical image analysis
Tetsu Kamitani
Associate Professor, Cardiology
M. D. Anderson Cancer Center
M.D., Toyama Medical and Pharmaceutical University, 1985
Ph.D., Toyama Medical and Pharmaceutical Universiry, 1990
Research interests: post-translational modification; regulation by ubiquitination; conjugation with ubiquitin-like prote in;
SUMO; NEDD8; proteolysis by
proteasome; function of NUBl;
ubiquitination by Ro52; ubiquitination by
TRIMS

Aarif Khakoo
Assistant Professor, Cardiology
M. D. Anderson Cancer Center
M.D., Columbia Universi ty, College of
Physicians and Surgeons, 1999
Research interests: cardiomyopathy; chemotherapy; receptor tyrosine kinases; platelet
derived growth factor; cell signaling; cardiac development; cardiac physiology
Jeri Kim
Associate Professor
Genitourinary Medical Oncology
M. D. Anderson Cancer Center
M.D.. University of Southern California,
School of Medicine, 1993
Research interests: prostate cancer prevention and treatment
Mikhail G. Kolonin
Assistant Professor
Centre for Stem Cell Research
UT-H Institute of Molecular Medicine
Ph.D., Wayne State University, 2000
Research interests: mesenchymal stem cells;
mechanisms of adult stem cell mobilization/
rnigration/engrafnnent; role of mesenchymal stem cells in cancer vasculogenesis; role
of adipose tissue/adipose stern cells in cancer progression
Frederick F. Lang
Professor/Director
Neurosurgery/Clinical Reseatch
M. D. Anderson Cancer Center
M.D., Yale Universiry School of Medicine,
1988
Research interests: role of end terminal
phosphorylation in p53-mediated apoptosis;
human mesenchymal stern cells as delivery
vehicles for gliomas; cancer stem cells in
brain tumor formation; animal models of
brain tumors
Dina Che1ouche Lev
Assistant Professor
Cancer Biology
M.D. Anderson Cancer Center
M.D., Sackler School of Medicine,
Tel Aviv University, 1993
Research interests: soft tissue sarcoma;
chemoresistance; angiogenesis;
lymphangiogenesis; metastasis; pre-clinical
therapeutic models; tumor microenvironment; gene therapy; p53 rumor suppressor
gene function; siRNA; signal transduction
pathways; tissue microarrays; high throughput assays
Hui-Kuan Lin
Assistant Professor
Molecular and Cellular Oncology
M. D. Anderson Cancer Center
Ph.D., University of Rochester, 2002
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Research interests: tumor suppressor gene/
oncogene in cancer development; protein
phosphorylation
Nami McCarty
Assistant Professor
Centre for Stem Cell Research
UT -H Institute of Molecular Medicine
Ph.D .. Purdue University, 2000
Research interests: h uman and mouse stem
cell differentiation; gene regulation; RNAi;
hematOpoietic stem cell development; T/B
cell development :md differentiation; auwimmune diseases
Sattva S. N eelapu
Assistant Professor
Lymphoma and Myeloma
M. D. Anderson Cancer Center
M.D., Jawaharial Institute of Post..(Jraduate Medical Education and Research, 1991
Research interests: tumor immunology; cancer vaccines; novel tumor antigen discovery; adoptive T -cell therapy; immunological monitoring; lymphoma
Andrew C. Papanicolaou
Professor and Director
Developmental Pediatrics/
Neurosurgery & Neurology
Cent e r for Clinica l Neurosciences,
Children's Learni ng Institute,
UT-11 Medical School; Diretor
Ph.D., Southe rn Illinois University at
Carbondale, 1977
Research interests: specification of brain
mechanisms of linguistic affective and cognitive functions; brain activity signs of deve lopmental disorde rs; localization of
sources of epileptiform activity
Laszlo G. Radva nyi
Associate Professor
Melanoma Medical Oncology
M. D. Anderson Cancer Center
Ph.D., University of Toronto, 1996
Researc h interests: rumor imm uno logy;
melanoma; breast cancer; immunotherapy;
adoptive T -cell therapy; tumor vaccines;
antigen discovery
Xiujiang John R ong
Assistant Professor, Imaging Physics
M. D. Anderson Cancer Center
Ph.D., University of Missouri • Columbia,
1996
Research imerests: radiation dosimetry;
medical image quality evaluation and mea·
surement; computed tomography; digital xray imaging
Dos D. Sarbassov
Assistanr Professor
Molecular and Cellular O ncology
M. D. Anderson Cancer Center
Ph.D., University of Arkansas for Medical
Sciences, 1997
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Research interests: cell signaling; regu lation
of cell growth, proliferation, survival, and
migrat ion; rapamycin and t he mTOR
(mammalian Target Of Rapamycin) pathway; kinases and phosphatases; anti-cancer
drug development
Robert J. Schwartz
Professor and Director
T exas A&M Un iversity Institute of Bio·
sciences and Technology
Director, Center for Molecular Development and Disease
Ph.D., Un iversity of Pennsylva nia, 1972
Resea rch interests: gene regulation; mechanisms in transcription; embryonic develop·
men t; formation of the cardiovascular sys·
tem; myogenesis; gene networks
Padmanee Sharma
Assistant Professor
Genitourinary Medical Oncology/
Immunology
M. D. Anderson Cancer Cenrer
M.D., Ph.D., Pennsylvania State Univer·
sity, College of Medicine, 1998
Research interests: immunological studies
re lated to genitourinary malignancies; development of future immunotherapeutic
strategies; role of effector and regulatory Tcells in anti-tumor immune responses; ru·
mor antigen expression and immune responses against tumor antigens; cytokine
profile in tumor microenvironment
Paul J. Simmons
Professor and Director
Centre for Srem Cell Research
UT-H Institute of Molecular Medicine
Ph.D., University of Manchester, 1985
Research interests: stem cell biology; mesenchymal stem cells; hematopoiesis; cell
adhesion molecules; stem cell mobilization;
skeletal biology; monoclonal antibodies
R obert Y. L. T sai
Assistant Professor
Center for Cancer and Stem Cell Biology
Institute of Biosciences and Technology
Texas A&M Health Science Center
M.D., National Taiwan U niversity, 1988
Ph.D., Johns llopkins University, 1996
Research interests: stem cells; neural stem
cells; neurodevelopment; neucleostem in;
aging; cancer; regeneration
YiXu
Assistant Professor
Center for Extracellular Matrix Biology
Texas A&M Univea:osity, Institute of
Biosciences and Technology
Ph.D., UT-H GSBS, 1998
Research interests: bacteria and host interactions; bacterial pathogenesis; host cellular machinery; innate immune response;
bacterial surface proteins

Qing Yi
Associate Professor
Lymphoma and Myeloma
M. D. Anderson Cancer Center
M.D., J iangxi Medical College, 1983
Ph.D., Karolinska Institute, 1993
Research interests: tumor immunology;
immunotherapy; dendritic cell vaccination;
antibody therapy; myeloma mouse models;
multiple myeloma
D ekai Zhan g
Assistant Professor
Center for Extracellular Matrix Biology
Texas A&M University Institute of
Biosciences and Technology
M.D., Harbin Medical College, 1993
Ph.D., University of Hong Kong, 1998
Research interests: innate immunity; pathogen-host interactions; inflammation and
infecrious diseases
Dapeng Zhou
Assistant. Professor
Melanoma Medical Oncology/
Imm unology
M. D. Anderson Cancer Center
M. D., Shanghai First Medical College, 1994
Ph.D., University of Zurich, 2000
Research interests: T cell biology; antigen
presentation; immunotherapy; therapeutic
vaccines

NE\\'
Associate Memlwrs
Ana M. Aparicio
Assistant Professor
Genitourinary Medical Oncology
M. D. Anderson Cancer Center
M.D., Universidad Autonoma de Madrid,
1995
Research interests: epigenerics; DNA methylation; DNA methylat ion inhibitors;
histone deacetylase inhibitors; prostate cancer; genitOurinary malignancies
Krishnakuma r Balasubramanian
Assistant Professor, Cancer Biology
M. D. Anderson Cancer Center
Ph.D., Institute of Microbial Technology,
1997
Research interests: mechanisms in apoptosis
and phagocytosis; resistance to drugs and
death ligands; metastasis and acqu isition of
metastatic potential
Tina Marie Briere
Instructor, Radiation Physics
M. D. Anderson Cancer Center
Ph.D., State University of New York at
Albany, 1995
Research interests: ga rrointestinal tumor
motion; in vivo patient dos imetry

Martin Bues
Instructor
Radiation Physics
M. D. Anderson Cancer Center
Ph.D., Harvard University, 1996
Research interests: proton therapy; intensity modulated radiation therapy; gated radiation therapy; prostate brachytherapy

Jennifer M. H oskovec
Clinical Instructor
Obstetrics, Gynecology and
Reproductive Sciences
UT-H Medical School
M.S., UT-H GSBS, 2003
Research interests: genetic counseling;
prenatal

Suhendan Ekmekcioglu
Assistant Professor
Experimental Therapeutics
M. D. Anderson Cancer Center
Ph.D., University of Istanbul, 1993
Research interests: signaling pathways in
melanoma; regulation of survival factors in
melanoma; molecular prognostic markers

Aaron K. Jones
Instructor, Imaging Physics
M. D. Anderson Cancer Center
Ph.D., University of Florida, 2006
Research imeresrs: optimization of diagnostic imaging protocols (especially pediatrics)
with regards to absorbed dose and image
quality; phantom design and construction;
radiation dosimete r design, construction
and testing; image quality assessment; image processing; computed tomography,
computed radiography, digital radiography

Suzanne L. Craig
Associate Professor
Veterinary Medicine & Surgery
M. D. Anderson Cancer Center
D.V.M., Tuskegee University School of
Veterinary Medicine, 1989
Research interests: ani mal models; experimental design; cancer biology; comparative
medicine; an imal imaging; immunology
William D. Erwin
Senior Medical Physicist, Imaging Physics
M. D. Anderson Cancer Center
M.S., DePaul University, 1991
Research interests: quantitative gamma
camera imaging; septal penetration; scatter
and attenuation corre c tion; iterative
SPECT reconstruction; hybrid SPECT/CT
imaging; yttrium-90 bremsstrahlung imaging; internal radionuclide dosimetry; radionuclide therapy treatment planning
Carl S. Hacker
Associate Professor
Management, Policy and
Community Health
UT -H School of Public Health
Ph.D., Rice University, 1968
J.D., University of Houston Law Center,
1987
Research interests: urban ecology;
vector biology; public health law and policy
Andrea E. Harbison
C linical Instructor
Pediatrics
UT-H Medical School
M.S., University of Cincinnati, 2005
Research interests: genetic counseling;
prenatal

Malgorzata Kloc
Associate Professor
Molecular Genetics
M.D. Anderson Cancer Center
Ph.D., Warsaw University, 1978
Research interests: development; ax ial patterning; RNA localization
Anita Mahajan
Associate Professor
Radiation Oncology
M. D. Anderson Cancer Center
M.D., McGill University, 1992
Research interests: stereotactic radiosurgery;
brain tumors; pediatric radiation oncology
Mark J. McArthur
Associate Professor
Veterinary Sciences
M. D. Anderson Cancer Center
D.V.M., Texas A & M University, 1979
Research interests: pathology of genetically
engineered mi.ce; p53; COX-2 in carcinogenesis; mouse models of pancreatic and
urinary bladder cancer
Ramaswamy Sadagopan
Senior Medical Physicist
Radiation Physics
M.D. Anderson Cancer Center
M.S., UT-H GSBS, 1989
Research interests: medical physics
Miguel A. Rodriguez-Bigas
Professor
Surgical Oncology

M. D. Anderson Cancer Center
M.D., University of Puerto Rico,
School of Medicine
Research interests: surgical o ncology;
colorectal cancer
David L. Schwartz
Assistant Professor
Radiation Oncology
M. D. Anderson Cancer Center
M.D., University of California
Los Angeles School of Medicine
Research interests: multi-modality molecular genetic imaging ofsmall animal preclinical models; head and neck; radiation oncology; medical imaging; radiobiology
C laire N. Singletary
Assistant Professor
Pediatrics
UT-Houston Medical School
Director, Genetic Counseling
S.M.S. Program
M.S., Northwestern University, 1998
Research interesrs: genetic counseling
Donna M. Stevens
Senior Medical Physicist
Imaging Physics
M. D. Anderson Cancer Center
M.S., University of Colorado Health
Sciences Center, I993
Research interests: medical physics; diagnostic radiological physics
Sastry Vedam
Assistant Professor
Radiation Physics
M. D. Anderson Cancer Center
Ph.D., Virginia Commonwealth University,
2003
Research inreresrs: respiratory motion management in radiotherapy; image guided rad iotherapy; 4D CT; 4D cone beam CT;
PET; 4D treatment planning and delivery
Alex C. Vidaeff
Associate Professor
Obstetrics, Gynecology & Reproductive
Sciences
UT-H Medical School
M.D., University of Bucharest, 1977
Research interests: hormonal regulation of
gene expression; genomic and non-genomic
effects of corticosteroids; prematurity
prevention
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Aaron Blanchard Research Award in Medical Physics
Named in memory of Aaron M. Blanchard, a GSBS sLudcnt in rhe Medical Physics Program who succumbed to brain cancer in 1998, lhb $300 cash award recognizes a Medical Physics graduate (M.D. or
Ph.D.) for completion of an outstanding thesis or dissertation judged to make a significant conrribution to
cancer therapy or diagnosis. This will become a formal award endowment in 2007-2008. Award recipient
for 2006-2007 is:
Student
Jennifer O'Daniel

Advisor
Dr. Lei Dong

American Legion Auxiliary Scholarship Awards
Since 197 .1 the Amencan Legion Auxiliary has
provided scholarships for GSBS sLUdents involved
in cancer research. The money for this fu nding is
raised through a wide range of Auxiliary activities. To date the Auxi liary has rai ed over
$1,100,000 to prescnL over 80 renewable sch olarships of $5,000 each. The 2006-2007 recipients are:

Student
Kendra Carmon
Jennifer Caner
Sarah Dunlap
Omar Duramad
Shannon Kidd

Advisor
Dr. David Loose
Dr. Subrata Sen
Dr. Wei Zhang
Dr. F. Xiao-Feng Q in
Dr. Paul Simmons

Student
Sabine Lange
John Latham
Athanasia Panopoulos
Nicole Pinaire
Joe Taube
Regina Weaks

Advisor
Dr. Karen Vasquez
Dr. Sharon Dent
Dr. Stephanie Warowich
Dr. Timothy McDonnell
Dr. Michelle Barton
Dr. David Johnson

R. \V. (Bill) Butcher Achievement Award
Established in 1977, the R. W. Bill Butcher Fund provides an annual award of $2,000 for a sntdem who
demonstrates excellence in research, has a commitment to a career in biomedical research, and makes a
professional contribution tO the community or has faced a particular challenge. This year's recipient is:
Student
Amber Johnson

Advisor
Dr. Michelle Barton

Harry S. & Isabel C. Cameron Foundation Fellowship
The Cameron Foundation provides a fellowship m an exceptional GSBS student working in research
fields related to Alzheimer's or cardiovascular diseases. The Foundation gift of$10,000 is matched by the
GSBS in 2006-2007 to provide a toml of $20,000 in stipend support to !he student. The 2006-2007
recipient is Xi Mo, whose studies may lead to novel therapeuLics ro treat bleeding disorders as well as
atherosclerosis and cardiovascular diseases.
Student
XiMo

Advisor

Dr. Renhao Li

Alfred G. Knudson OutstaoPing Dissertation
In 1997 an annual Alfred G. Knudson Outsmnding Dissertation Awa rd was established by M. D. Anderson
Cancer Cenrer ro honor this distinguished individual and former GSBS dean. The $1,000 award is given to
a graduate of !he GSBS whose dissertaLion is selected as the most outstanding in cancer rese;
year's recipient is:
Student
Ruoning Wang

16

Advisor
Dr. )ian Kuang

stu£~
William W. and Pearl Wallis Knox Foundation Scholar
Esr:~b lished in 2007, this is the fi rst year to award a Scholarship from the Knox Foundation, whose inter·
ests arc research in the areas of A IDS and other infectious diseases in humans. This $2,500 award was
presented to:

Student
Cana Ross

Advisor

Dr. Theresa Koehler

City Federation of Women's Clubs Scholar
Established in 2005, th is $2,000 Scho larship rewards an exceptional GSBS student who is work ing in an
area vital to the biomed ical sciences and of particular currem significance in that year's national research
for this scholarship. For 2006-2007 this scholarship recognizes research in the axea of Stem Cells.
Student
Advisor
Shannon Kidd
Dr. Paul Simmons

T. C. Hsu Endowed Memorial Scholarship
To remember Dr. Hsu, and his remarkable research work, his daughter Margaxet, M. D. Anderson Cancer
Center Foundation, colleagues, faculty, friends and former students of Dr. Hsu established this memorial
scholarship in 2003. The scho larship is a living testimony and serves to acknowledge the stellar research
accomplishments of graduate students focusing on his areas of research, genetics and cell bio logy. The 20062007 recipient is Dung-Fang l ee, whose research studies will provide a more thorough understanding in
inflammation -induced tumor deve lopment.
Student
Dung-Fang (Ben) Lee

Advisor

Dr. Mien-Chie Hung

Rosalie B. Hite Fellow~
In 1946 H ouston citizen Rosalie B. Hire left her entire estate ro establish a fellowship program for cancer research. This award includes
a stipend of$25,000 per year, tuition and fees, and a single travel allowance up to $850 for each student to present his or her research at
a national meeting. The 2006-2007 recipients are: Hannah Cheung (Dr. G il Cote, advisor), Yumin Hu (Dr. Peng Huang, adv isor),
Shannon Kidd (Or. Paul S immons, advisor), Stephen Kry (Dr. Mohammad Salehpour, adv isor), Taichun Qin (Dr. Jean Pierre lssa,
adv isor).

Presidents' Scholars
Through funding from President James Willcrson, UT Health Science Center at llous·
ton, and President John Mendelsohn, UT M. D. Anderson Cancer Center, rhis $5,000
award is given to four advanced GSBS students who have demonstrated excellence in
reseaxch.
Student
Ruoning Wang
A thanasia Panopoulos
Melissa Adams
Stephen Kry

Advisors
Dr. ]ian Kuang
Dr. Stephanie Watowich
Dr. Phillip Carpenter
Or. Mohammad Salehpour

Michael Farley Moyers Heavy Particle Therapy Travel Endowed Award
In 2006 GSBS Alumnus Michael F. Moyers, Ph.D. (1991/Horton) created this awaxd to provide travel support
for an exceptional Medical Physics student who has had a paper accepted at the American Association of
Physicists in Medicine (AAPM) to attend the annual meeting. Jonas Fonrenor received the Cameron Yo ung
ln vestig-.:~tor's Award from AAPM, and in rum is the first recipient of the Moyers Award of $500.
Student
Jo nas Fontenot

Advisor
Dr. Wayne Newhauser
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rds
John P. McGovern, M.D., Scientific Poster Competion
M.S. Category
1st:
2nd:
3rd:
4th

Student
Bahareh Tavana
Rosanna lsaguirre
Sara Spikes
Violetta Chavez

Ph.D. Pre-Candidacy Category
1st:
Sharon Way
2nd
Eliseo Castillo
3rd
Wade Kothmann
4th
Chris Singh
Ph.D. Post-Candidacy Category
1st:
Yen-Michael Hsu
2nd:
Kimberly Manklewicz
3rd:
Brett Chiquct
4th
Charles Chung

Advisor
Or. Zahid Siddik
Dr. Raymond Grill
Dr. Gregory May
Dr. Daniclle Garsin

Thank you to our judges:

Drs. Joseph Alcorn, Hesham Amin, Diane Sick,

Dr. Michael Gambello
Dr. Kimberly Schluns
Or. John O'Brien
Dr. Chinnaswamy Jagannath

Phillip Carpenter, Irma Gigli, Vidya
Gopalaknshnan, Mtchacl Hallman, Constantin
loannides, Theresa Koehler, Dina Lev, Shiaw-Yih
Lin, Anita Mahajan, Hector Martinez-Valde.:,
Osama Mawlawt, RaJagopal Ramesh, Georgto
Rassidakis, Subrata Sen, Ana Tari, Robert Well ,
Yinhua Yu, and to Career Development presenter,
Dr. Joya Chandra.

tfts/1/fc

Dr. Xin Li n
Dr. Vasanthi jayaraman
Dr. jacqueline Heche
Dr. james Hixson

Dec S. & Patricia Osborne Endowed Scholarship in the Neurosciences
'

.lllf'6

tt "'
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Established by the Linda and Ronny Finger Foundation in 2001-2002, this endowed scholarship honors
former University of Texas Health Science Center at Houston Development Board president, Dee O..bome
and his wife PatTicia. Through the endowment an award of$1,000 is provided to the winning presenter in
the graduate student category at the Annual Neuroscience Scientific Poster Session, and an additional
SSOO ~tllormenc is given for trave l for presentation at a scientific meeting. This award is presented during
Brain Awareness Week. This year's recipient was:
Student
Feng Pan

Advisor
Dr. Stephen Massey

Sam Taub & Beatrice Burton Scholarship in Vision Disease
In 2004 this $2,000 award was establt hed by Mary Wright and her sister, Joanna Ross, in honor of their
grandfacher and great aunt co support students with research in the area of sight-related vision problems, and
the genetics and potential therapies behind these life-changing health concerns. The 2006-2007 recipient
tS:

Student
Catherine Spellicy

Advisor
Dr. Stephen Dlliger

Roberta M. & Jean M. Worsham Endowed Scholar!thip
in the Behavorial and Neurosciences
Formally presented during Bram Awareness Week this endowed scholarship of$ 1,000 fosters exceptional
students working in the fields of the behavioral or neurosciences Wtth a focus on the areas of addiction or
obse~sivc/compulsive behavior. T h e recipient for 2006-2007 is:
Student
A imee Lake

Advisor
Dr. Mark Bedford

Graduate Student Education Committee at the Medical School Research Poster Competition:
I t place: $400; 2nd place: $300; 3rd place: $200.
First Place, Sharon Way (Or. Michael Gambello, advisor); Second Place ties: Wade Kothmann (Dr. John O'Brien, advisor) and Feng
Pan (Dr. Stephen Mas ey, advisor); Third Place ties: C hris Wilson (Dr. Heinrich Taegtmeyer, advisor), Leslie Piggott, (Dr. Carmen
Dessauer, advisor), H anyin C heng, (Dr. Robert Kirken, advisor), Kimberly Mankiewicz (Dr. Vansamhi jayaraman, advisor).
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The Schissler Foundation Fellowships
This dynamic family foundation has been a major benefactor to the Graduate
School of Biomedical Sciences for over ten years and has sincere commitment to the belief in graduate education. These fellowships foster collaboration with the emphasis on basic science projects with a high likelihood of
translational application to human health, and the requiremen~ that all studen~ receive a broad ex-posure tO the biomedical sciences and ethical concepts that underlie their research. This prestigious award, with the ever more
directed focus on research studies will continue to make significant contributions to the therapies and CLtres of common human disease through genetics.
In 2006-2007 they have pledged rhree years of fu ll stipend and ru irion fu ndi ng for 4 Schissler Foundation Fellowships with at least one
expressly designated for a swdent working on cancer research with faculty at M. D. Anderson Cancer Center. The 2006-2007 recipients are:
Schissler Foundation Fellows in the Genetics of Common H uman Diseases
Student
Advisor
Andrea Lafom
Dr. Dianna Milewicz
Yen-Michael Hsu
Dr. Xin Lin
Charles Chung
Dr. )arne Hixson
Schissler Foundation Fellow in Cancer Research at M. D. Anderson Cancer Center
Student
Advisor
Omar Duramad
Dr. F. Xiao-Feng Qin

Andrew Sowell,Wade Huggins Endowed Scholars, Professor and Fellow
Cancer Answers/Sylvan Rodriguez Scholar
The Andrew Sowell-Wade Huggins Scholars, Professor and Fellow along with the Cancer Answers/Sylvan Rodriguez Scholar represent
the culmination of sixteen years of determined support and growth of the Cancer Answers charitable organization through rwo founding mothers, Joann Sowell and Marcia Huggins Jahncke, their fami lies, cancer survivors, and comributing foundations including the
Vivian L. Smith Foundation, Sylvan Rodriguez Charities, Bridgway Capital Managemem, and especially Bobby Sue Smith Cohn and
Bo and Amy Huggins. Originally started as the fund raising entity to support the Andrew Sewell-Wade Huggins Endowment which
generates all of these awards LO fu nd graduate education in cancer research, it has gained in size and prestige. Since 1991 a total of 48
scholars and 3 sets of professor/fellow reams (renewable up m three years) have been honored with awards ranging from $2,500 up w
$20,000 in stipend support. The 2006-2007 recipients include:

Andrew Sowell-Wade Huggins Scholars
Student
Advisor
Dr. Richard Ford
Lmgchen Fu
Yen Michael Hsu
Dr. Xin Lin
Dr. Mien-Chie Hung
Dung-Fang (Ben) Lee
Nicole Pinaire
Dr.Timothy McD01mell
Cancer Answers/Sylvan Rodriguez Scholar
Stephen Kry
Dr. Mohammad Salehpour

Andrew Sowell-Wade Huggi ns
Professor and G raduate Fellow
Or. Gary Gallick and Jing Zhang

Student

NEWS
.,co7..oq

GSA Officers

Yen-Michael H su, Vice President
MDACC. Molecular & Cellular O ncology
Melan ie D ujka, President
MDACC, Immunology
Violetta Chavez, Secretary
UTHSC, Microbiology & Molecular Generics

Farewell (many thanks) .•.
2006-2007 GSA Officers:
Pat G ibney, President, UTHSC
Microbto logy & Mo lecular Genetics
Brett Ch iquett, Vice President, UTI ISC
Pediatrics
Nicole Pinaire, Secretary, MDACC
Molecular Patho logy

2007 Career Day for Students sponsored by the GSBS Alumni Association

Career Development
by
Jon R. Wiener, Ph.D., Assistant Dean
Academic Affairs
Many students begin their education at graduate
schools of biomedical sciences throughout the world with·
out a clear plan for their career~. This is completely under·
standable and even cxpccteJ. How can one prepare l1>ng·
range career plans when rhey are just heginnmg to t''<pcri·
ence research in a graduate school setting?
Numerous survey~ indtcare that approxtmately
80% of studen~ enter graduate biomedical science program~
with the expectation that they will eventually be a faculty
member at a university. However, the data indicates th<\t
approximately only 35% of studems eventually do become
tenured or tenure-track faculty members by I0 years postgraduation. There i~ lhcrefore a considerable gap between
early expectations and thl' rt•al world .
The questiom all graduate schools in biomedical
sciences should thus he asking themselves are: How are we
preparing our students for the real work-world? How do we
heir our students finc.l the niche they are best suited ior,
and prepare them ro obrain the positions they seek? And,
how early in their training should students be recei\'ing
career development advice?
Studen~ in the prc~ent era arc fortunate to be able
to pursue varied awnu<.'s of ntrcer options, :>~ II of which arc
viable for a career in the hinmedtcal sciences. Not only
may sruden~ pursue academic faculty positions as they have
for generations, but a:. wdl, they may pursue positions in
indu5trial research, potent l.nv, scientific writing, tcchnol·
ogy transfer, public pdicy, con~ulting, and sales, ro name a
few, and with as much variety as maintaining a research
career track with benchwl)rk, or becoming a medical llai~on, and never see the bench again. A generation ago, a
choice of any option mhcr than academia w::~s considl'red
'selling out.' Now it i:; consillercd not only wise to consider
non-academic options, but indeed narrow-minded to not
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consider these possibilities, many of which have incrca~cd
opportunities for ~clcmific: travel, nmuwn, and financial remuneration.
Graduate schools must take on rhe responsibility
to provide career development opportunities for their ~tu·
denrs. Schools which 'bury their heads in the sand' and elect
to nor provide cc.lucatiunalopponunities in career development for rheir studen~ arc qu1te Simply liuuting the chances
for their graduates ro become valued membe~ of the global
biomedical community. Schools desire their graduates ro
succeed, not on ly tu briug regard to the school as a Jisrin·
guished graduates, hut also to assisr in the recruirment nf
the next generation of scientists, and ro bring in develop·
mcnt funds to assist the training of present and future students. In this golden ::~ge of biomedical science, all schools
must assist their students in seeking, finding, and preparing
for positions in all the vari<.·d career choices that are now
a\'ailable to them.
The GSBS, as a part of the UT Health Science
Center at Houston, in partnership with the UT M.D. Ander·
~n Cancer Center, endeavor" to provide career devclnpment training for GSBS students. A combination of week·
end workshops, career fairs, and a full seminar series has already been set up. In add1t1on, the GSBS Alumni Associa·
tion has developed an 'c-mentoring' program, an extremely
valuable on-line resource that matches current students with
alumni from the GSBS who work m various careers in rhe
biomedical sciences, in <ln effort to provide ~tudents with
real-life advic.:t on the cmeer:. they are considering. Many
of these alumni also speak ar the Annual Career Fair. Check
It out at~
http://gshs.uth.tmc.edu/alumnVinreach_pamcipanrs.html
Finally, we arc always thinking of ways we can adJ
more opportunities for the students to learn ahout their career options. Students should avail themselves of all of these
resources, and begin doing so early in their training, to acquire the. information they need to make wise career choices.

Staff NEWS
STAR TEAM

OurGSBS Staff was presented with The University of T exas
H ealth Science Center at H ouston Star T eam Award and
$5,000 to benefit the Staff anJ School. "The Three Musketeers philo ophy-all for one anti one for all" and a willingness to go the extra d istance for :.tudenrs, faculty and community made the difference. Here left to right: Gina
C h appell, Brenda Gaughan, Lily D'Agostino, Jeannice
Theriot, Carol He lton, Alice Hatcher, Linda Carter, Bunny
Perez, Angela Doggett, Mich ae l Valladolid, T o m Goka,
Vicki Knutson, Heidi Porter, Liz Stamey, T y Williams,
Cheryl Spitzcnberger, Mary Yehle, Karen Weinberg, Jon
Wiener, Paul Darlington.

Distinguished Visitor

LEADERSHIP /\WARD
Paul Darlington, Ph .D., Associate Dean
of the GSBS, received the 2007 Michael
J. Jimenez Leadership in Action Award
from UT-Health Science Center. This
award was established in memory of the
late Mike Jimenez, former vice president
and chief human resources officer at the
UT Health Science Cen ter. It is given
for demonstrating a commitment to collaboration and productive re lationships with facu lty and staff at all levels of
the organization; energy and enthusiasm for the work of the
univer·iry; a consistently po itive attitude; and a commitment to do the right thing.

Melva S. Ramsay AWARD
Carol H elton, Administrative Assistant for Finance and Per onnel, is ,
the 2007 recipient of the GSBS
Melva S. Ramsay Award for outstanding service to faculty, rudents,
and staff. The award of $500 (and
fl owers) is presented by Geo rge
Stanccl, dean of the GSBS.

President James Willerson, Dean George Stance!, and
Minister of Education and Training of Vietnam, Professor
Nguyen Thien Nban, is being presented here with a
photo of the Houston Texas Medical Center.

Hellooo. . . NEW GSBS STAFF
Joy Lademora has join ed the team in the
Academic Affa irs Office and assists Deans
Jon Wiener and Thomas Goka. joy received her M.S. from the University of Manila and is newly married after moving here
from the Phill ipines. Her favorile hobby is
volleyball where she is a seri ous center
spiker.
Michael Valladolid is our new IT Systems
and Applications Specialist. Mike graduated from the University of Delaware, i
married <md keeps busy (when. be's not at
GSBS) with his wife, 18 month o ld son, and
two dogs. For reh-1xarion he takes long walks
on the beach.
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Distinguished Alumnus 2006..2007
John J<opchick, Ph.D.
Growth Hormone, Mice, Football, Dirty Shorts and a New Drug

I am still amazed that a molecule secreted by the
pituitary gland, namely growth hormone (GH), directs both
anabolic and catabo lic processes. This is best seen when
recombinant G il is administered to growing pigs wherein
one observes a decrease in fat, and an increase in bone and
muscle. What a wonderful molecule! These observations,
made in the early 1980s, may have been somewhat ordinary
co a physiologist, but were quite remarkable to a molecular
biologist, in particular me! It started my scientific path of
attempting to de£ine the molecular mechanism(s) of GH
action. We arc still attempting to do this.
One simple-minded concept that could account
for the multiple activities of G H was co hypothesize that
the molecule had different "domains• and chat these do·
mains were responsible for the various activities of the hormone. This was our thought process in the mid 1980s. We
set out co test this hypothesis by performing structure/function studies. Basically, we changed G H's structure and
determined the affect on function. These altered GH mol·
ecules were collecttvely termed GH analogs.
It was the widely held opinion among endocrinologists that if one were to change the structure of a peptide
hormone, those changes should result in altered interac·
tions or binding properties of the molecule to its cognate
G H receptor. Although l believed chis basic maxim and
performed the classical in vitro receptor binding studies, I
also thought that a cell based or in vivo reporter system ulti·
mately would generate additional information concerning
the molecule's activity. This is where transgenic mice come
into play.
Mice that possess and express extra copies of G I-l
genes (GH transgenic mice) are larger than their nonnal,
non-transgenic siblings. We decided to study the activity
of the G H analogs in vitro using classic receptor binding
protocols and in vivo via growth enhancement of transgenic
mice. Thus, we would change the GH molecule via amino
acid substitutions or deletions, isolate the altered hormones,
perform GHR binding studies, and generate transgenic mice
that expressed the mutated DNA encoding the GH analogs. We expected that as the in vitro binding of the G H
analogs LO the GHR decreased, a corresponding loss of
growth enhancement in the transgenic mice would occur.
This was indeed the case for many of the G H ana·
logs. (By the way, G H possesses 191 amino acids and we
have changed nearly all of them).
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I now need to describe G H in terms of its topology.
The crystal structure of the molecule has been solved and
shows that it contains four a.-helices. a-helix number 3 has
amphipathic characteristics, that is, the charged or h ydrophilic amino acids are separated from the non-polar or hydrophobic amino acids. However, there is one hydrophilic
amino acid in the "sea" of hydrophobic residues, and one
hydrophobic am ino acid and a glycine residue in the h ydro·
philic area. O ne of our first alterations was to change these
three amino acids in the third a.-helix to make the molecule
a "perfect" amphtpathic a.-helix that is, an a.-helix with a
complete hydrophobic domain juxtaposed to a full hydrophilic area. In doing this, we anticipated that we would
increase the activity o r potency of G H with high expecta·
tions of generating a molecule that would bind to the G HR
with higher affinity than native GH and that would gener·
ate "really big mice."
If one expects a molecule to be more potent in its
biological activities than the original molecule, the dogma
of the pharmacology would predict that it should interact
with its receptor "better." When we performed the experi·
ments, we found that this "perfect" G H analog bound to
GHR with the same characteristic as normal GH; it did
not bind with higher affinity. We were terribly depressed
with these resulLS and were ready to "throw it our." Fortu·
natcly, we were so convinced that this perfect third a.-helix
should possess an altered activity that we generated the cor·
responding G H ana log transgenic mice. T o our surprise,
instead of generating a giant mou e, we obtained a small
mouse. In fact, it was approximately one-half the size of
normal mice. We have affectionately named this mouse
"Mini." (We aren't very original, are we?) We went on to
how that chis molecule was acting as a classic antagonist.
This was the first description of a large protein antagonist
and certa inly the first G H antagonist.
We subsequently changed these three amino acids, one at a rime, and found that it was not the three changes
but only the glycine at position 120 in human Gil that was
W1lportant for the activity of the molecule. When this glycine, located ncar the middle of the third a.-helix, was
changed to any other amino acid other than alanine, a G H
molecule that inhibited growth was generated. Thus, one
amino acid change out of 191 converted GH from a growth
promoter to a growth suppressor or a GH antagonist.
From my years in the pharmaceutical industry, it

was "drilled' into my subconscious that anything that inhib- and as he recounts, "could not sleep the remainder of the
ited a physiological process in vivo could be of potential value. night." He was incredibly excited about the GH antagonist
For example, there are many instances of drugs that inhibit and potential uses, especially for acromegaly. Now, we had
enzymatic activity or those that inhibit hormonal action. two individuals excited, Rick and me.
Since we discovered a GH antagonist, i.e. a molecule that
Rick, John Scarlett {a friend of Rick's) and I formed
inhibited GH action, I thought that it might have clinical a company called Innovations in Drug Development whose
value. After many hours in clinical libraries, I came up with name was subsequently changed to Sensus, a virtual comthree potential uses for a GH antagonist: for the treatment pany that out sourced all of its developmental resources.
of acromegaly, diabetic end organ damage, and certain types There was a small but extremely dedicated and competent
of cancers. I quickly wrote a proposal in which l described group of individuals within Sensus who shou ld be commended
the discovery and use of the GH antagonist. After submit- for the development of the GH antagonist along with the
ting the proposal to just about all of the large pharmaceuti- many clinicians who perfonned the clinical trials for acromecal companies and giving numerous presentations on the galic individuals. The data shows that the GH antagonist
discovery and potential uses of the GH antagonist, I was was efficacous in -90% of these patients. The FDA is now
somewhat depressed (again!!) in that there were no "tak- reviewing the data. Pham1acia Corp. will market the drug,
ers." Two large companies expressed some interest in the now called Somavert (pegvisomant for injection), if and when
GH antagonist for the treatment of diabetic end organ dam- it is approved. Hopefully, it will also be tested for other indiage, but none were interested in acromegaly, a condition cations including cancer and diabetic end organ damage.
caused by pituitary tumors that secrete GH.
Thus, a combination of unanticipated scientific reI took out my frustrations concerning the lack of sults, coupled with several serendipitous social events ultiinterest of the pharmaceutical industry for GH antagonists mately resulted in a new drug that will benefit many indiby performing physical exercise, especially with the Ohio viduals.
University football coaches. They put me through some
There could be many take home messages from this
very agonizing drills. One of the coaches, the late Joe Dean, story but the two I like best are: "Be careful not to throw out
would routinely ask what I was doing in the laboratory. As the phone number with the wash" or "Football coaches can
we were straining on a weight lifting machine, I happened be smart!!!! "
to tell him that we had discovered a potential drug but no
*I would like to acknowledge everyone who contributed to
one was interested. He relayed to me that one of his former
the discovery and development of GH antagonists. The list
students and football players, Richard Hawkins, knew "someis formidable, however, I'd like to particularly acknowledge
thing about drugs." Rick was founder and CEO of a drug
Wen Chen, Nick Okada, Tim Coleman, Joe Dean, Rick
development company called Pharmaco, Inc. Joe scribbled
Hawkins, John Scarlett, Peter Trainer and all of the other
Rick's phone number on a piece of scrap paper and said that
clinicians who performed the clinical trials, Lawrence and
I should give him a call. Frankly, I misplaced the number
Milcon Goll , and Ohio University.
with my soiled workout clothes. Luckily, my wife found the
wrinkled and "clean" piece of paper in the washing machine. **This story is dedicated to the memory of]oe Dean.
Several days later when in the process of writing
John J. Kopchick, Ph.D. is the Goii-Ohio Professor of Moan NIH proposal and day dreaming, l decided to call Rick.
lecular Biology at Ohio University. Also, he is head of the
After an enjoyable conversation, he asked me to send him
Growth, Obesity, and Diabetes group in the Edison Biotechmy proposal concerning the discovery and use of the GH
nology Institute as well as Professor in the Biomedical Sciantagonist. I sent it to him by overnight mail. About one
ences Department in the College of Osteopathic Medicine
week later, he called and asked why I did not send him the
at Ohio University.
proposal. 1said that l had. He subsequently found it on his
desk in one of the many mountains of paperwork. That "Mini Mice, Football, and Dirty Shorts" John J. Kopchick,
13.
night, during a bout with insomia, Rick
proposal The Endocrinologist: Autumn 2001, Number 61,
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Leposava Antonovic
Richard Bartlett
Yanis Boumber
Valentine Goodrich &}\ling
Joan Breuer McHam
I vone BrLu10
Joya Chandra
Vicky Estrera
Siqing Fu
Tom Goka
Maureen Goode
Richard Hajek
Julie Harless
Peng Huang
John Kopchick
Joshua Krumenacker
Xiaotao Li
Joy Marshall
Milton Marshall
Shirlette Milron

Catherine Moya
Jennifer Newcomb-Femandez
Bay Van Nguyen
Karen Niederreither
Jiangong N iu
Mustafa Ozen
Jacqueline Peltier Horn
Mary Riser
Zheng (Jane) Shi
Cynthia Skinner-DeBord
Ben Thomas
Deidre Vedder
Brenda Whaley
David Wildrick
Thomas Wood
Kendra Woods
Wan-Song Wun
Jianhua Yang
Dihu<t Yu
Hong Zhang

..
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Ucla Anestidou
Elizabeth Bruckhcimer
Cherie Buns
Tsung-Cheng Chang
'Chi-Ping Day
Sandeep Dayal
Zuoming Dcng
Stephen Hewitt
Howard Hubbell
Raegan Hum
Lingxia Jiang
Jeffrey Kiefer
Gene Lang

Mercedes Meyer
Sana Pratt
Joye Purser
Ashurosh Rao
Ana Robles
Thomas Roesel
Travis Vaught
Simon Williams
Virginia Wray
Wayne Wray
Monica Zamisch
Jean Claude Zenklusen
Alan Z<lrrinneshan

news flash
Geetha Achan ta, Ph.D. (2004) is a science communicator
for the Internationa l Nutrition Compan y BY, a
neutriceutical company in The Netherlands.
Gabriela Bowden, Ph.D. ( 1999) (Reuters) published in the
journal Science, led a study of the toxic Staph ylococcus aureus
bacteria and noted that it can pass one an other the gene for
the toxin Panton Valentine leukocidin (PVL) which itself
causes pneumonia.
Understandi ng that could provide a way to develop new
drugs or vaccines and shed light on how bacteria acquire
new and dangerous qualities.
D awn C handler, Ph.D. ( 1998) is a new assistant professor
in the department of pediatrics and the center for ch ildhood cancer at O h io State University, Columbus, O H.
Keith Chan, Ph.D. (2004) postdoctoral fellow at Stanfo rd
University was just awarded his first NCI K99 grant.
Antonio Chiocca, M.D.,Ph.D. ( 1998) neurosurgeon at
Ohio State University Medical Center for both research and
chnical activities in both surgery and cancer care has been
selected to receive the 2007 Grass Prize in Neurosurgery.
Vick y Estrera, Ph.D. (2001} is the PI for a new NIH MARC
(Minority Access to Re:.earch Careers} grant of $300,000
over five years at the University of Houston-Down town.
This grant will bring five o r six students a year to GSBS for
summer research with the potential of becoming GSBS students upon graduation. Fellow alumni and GSBS assistant
dean for minority affairs, Thomas Goka, Ph.D. (1974) will
work with Dr. Estrera to coordinate the summer program.
Valentine Goodrich-Boving, Ph.D. (1969) nominated in
memory, T . C. llsu, Ph.D., for a conference room at SigmaGcnosys, W oodlands, TX biotech firm . Dr. Boving is newly
appointed as S r. Improvement Advisor in C linical O perations at UT-M. D. Anderson Cancer Center.
Ronald Harwerth, Ph.D. ( 197 L) curren tly a Un iversity of
HoustOn professor, received the American Academy of
OptOmetry's Charles F. Prentice Medal Award.
Leslie H odges-Gallagher, Ph.D. (2002) started a new position as Director of Molecular biology at Combithera, a new
biotech company developing products that combine small
molecule signaling inh ibitors with endocrine therapies for
hormone-related cancers.
Elizabeth Oldham Hileman, Ph.D. (2003} newly appointed
to Project Director a UT-M. D. Anderson Cancer Cen ter's
External Collaborations office of Technology Discovery.
Dorrie Lamb, Ph.D. ( 1980) was recently appointed to the
Lester and Sue Smith C hair in Urologic Research at Baylor
College of Medicine (BCM). According to another GSBS
alumni, T imothy Boone, M.D., Ph.D. (1985) and awardwinning head of the uro logic department at BCM, "Dorrie
has built a world class laboratory and her mentorshi p to
young invesligators is a sh ining example to the entire
college."
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Hui-Wen Lo, P h.D. ( 1994) is a new assistant professor in
the division of experimemal surgery at Duke University
Medical Center, Durham, NC.
P ierrette Lo, M.S. (2002) joins Texas Heart Institute as a
scientific writer.
Maribelis R uiz, Ph.D. (2003) re-located as medical science
liaison for Abbott Laboratories in San Juan, PR.
Shankar Sellappan, Ph.D. (2005) While at Frost & Sullivan
has received a license (parent award) on his use of the LICOR
Biosciences' Odyssey System, in large part as a result of his
work as a GSBS student while in the lab of Dihua Yu, M.D.,
Ph.D. ( 1991) alumni and UT -M. D. Anderson faculty member. T his mechanism opens up new avenues for protein expression research.
Aurora Seminara, Ph.D. (2005) is the new Scien tific Director at ProHealth, a division of Draftfcb Health care in
New York.
Zheng (Jane) Shi, P h.D. (200 1) is a patent agent an d attending law school.
Debra Wallis, Ph.D. ( 1999) opened a coffee shop and catering business "Central Perks" in Marshall, TX.
Kendra Woods, Ph.D. (1995) during UT -M. D. Anderson's
Cancer Center partnersh ip launch met with their Royal Jordan ian Highnesses Ghida and Dina in Amman, Jordan, and
mo t recently Pre ident an d Mrs. George Bush.
Wanting (Allison} Xu, Ph.D. (1999) is assistant professor,
Diabete Center and the Departmen t of Anawmy, University of California, San Francisco.

Tom Piantanida, Ph.D . (1972)
"I've hcen involved in color vision genetics, and in fact shared the NewcombCleveland Prize from AAAS for sequencing the genes that encode the human color-vision pigments. I had a nice
career al SRI where the philosophy was that I could do
anything I wanted to J o, as long as I could find someone ro pay for it. So, I worked in stabilized-image research, invented a non-invasive intracranial pressure
mom tor, a telemetry SID$ monitor, researched the "filling-in" mechanism, whtch keeps us from seeing our own
hlindspor-it d()C:) much more than that, and it is critical to stercmcopic vision-and I started a virtual reality
lah to research the perceptual effects of VR technology.
When I tarred GSBS , one of my Professors - Bob
Benolken, as I recall • to ld me that the purpose of the
Core Program was to prepare any GSBS Graduate to
hold up hts end of a conversation at a cocktail parry at
Cambndge. That "generalbt" attitude has provtded
me with more than a few research prOJects over the
years. And, yes, tt has enabled me to converse with a
wide v,uiery of scientists, sometimes drawing on tidhits gleaned from the Core Program."

5PECI Al
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Cullen Trust for Higher Education

Cullen Trust for Higher Education made this record Leadership gift of $1,115,000 to the Graduate School for the
putpose of underwriting its M.D./Ph.D~ program. Organized through the GSBS, the gift provides dramatic growth
opportunities for students in the program at UT~Houston MediCal School, UT,M. D. AndersonCancer Center1 and
the Baylor College of Medicine Graduate School of Biomedical Sciences.

Our Donors

Our Benefactors
The Blackwell Foundation
Cancer Answers, Inc.
Harry S. & Isabel C.
Cameron Foundation
Mimi Cho,Rohlfsen
S. Stacy Eastland
Irma Gigli
David M. Grimes II
George Ann Harding
Diana Hawkins
Margaret Hsu
Geoffrey Ibbott
Rodney Kellems
Robert W. & Pearl W.
Knox Foundation
John Kopchick
Anand Lagoo
Sandhya LagooDeenadayalan
Fred & Marilyn Lummis
Kevin Morano
John P. McGovern
Foundation
Peggy O'Neill
John Powers
Melva Ramsay
Randall Rupp
The Schissler Foundation
Joel Staff
Douglas Stickle
Karen Storthz
Ralph Thomas
Deidre Vedder
Danny Welch
Tom & Mary Ruth
Williams
Jean & Roberta Worsham
Wan-Song Wun
WeiYu

Greg Aune
Melissa Aldrich
j ohn Amolak
Frances Arrighi
Michael Badzioch
Michelle Barton
Caro l Blanchard
Timothy Boone
Paul Borchardt
Yanis Boumber
Valentine Boving
Joan Breuer-McHam
L. Maxmilian Buja
William Butcher
Daniel Carson
Linda Carter
Roberr Chamberla in
Stacey Champion
Sh ine Chang
Tse-Chang C heng
Esther Cheung
Madelene Coombes
Gi lbert Cote
Quita Cruciger
Stephen lf<~iger
Peter Davies
Zuoming Deng
Carmen Dessauer
Donna DiPaolo
Herbert Dupont
Jul ie Ellerhorst
Cindee Ewell
Frank Fasullo
Isaiah Fid ler
Ralph Freedman
Rhonda Friedbert
Jeffrey Frost
Yasuhide Furuta
Gary Gallick & Jan Liang
Brenda Gaughan
Eugene Gerner
Armand G lassman
Millicent Goldschmidt
Jason Goldsmith
Siew-Ging Gong
Yi-Zhong Gu
James Gum
Dianne Hammond
Steven Hanks
Carol Helton

Stephen Hewitt
Beng and Dah Hsi Ho
Kenneth Hegstrom
G lenn Housholder
Jen -Tza Huang
Mien -Chie Hung
Gary Johanning
Faye Johnson
Jeffrey Johnson
Daniel jones
Hitesh Kapadia
Norman Karin
Robert Kirken
W illiam Klein
James Knierim
Ralf Krahe
Zvon imir Krajcer
Robert Ku
M. Tien Kuo
John Kurland
Gary Kurzban
Richard Lane
Matthew Lawrenz
George Leventon
Xin Lin
Yun Lin
Carol Linsner
Pu Liu
Kathryn Louie
Karen Lu
Tom & Nancy Matney
Beth Lynn Maxwe ll
Pierre McCrea
Richard Meisch
Marvin Meistrich
Raymond Meyn
Shirlen e Milton
Yuko Miyamoto
Radhe Mohan
Kevin Morano
Debra Moss
JoAnn Mou lds
Shahla Nader Eftekhari
Jennifer NewcombFernandez
Sarah Nobl in
Hope Northmp
Grier Page
Nickolas Papadopoulos
T ed Pate

Sen Pathak
Deborah Pearson
Jacquel ine Peltier-Hom
Berty Petrie
Heidemarie Porrer
Karl Prado
Janet Price
Usman Qazi
Donna Reeve
Ellen Richie
T homas Roesel
Aaron Roome
Joyce Rundhaug
Jeffrey Safran
Barbara Sanborn
Priscilla Saunders
William Schull
Stanley Schultz
Leanne Scott
Robert Shalek
Bardett Sheinberg
Donna Sheach
Zheng Shi
Ann-Bin Shyu
Malcolm Skolnick
Ani l Sood
Cheryl Spitzenberger
George Srarkschall
James Strong
Gulnar Su(Veyor
Hei mich Taegtmeyer
Ming Tang
Ba-Bie T eng
Jeannice Theriot
Chadwick Thompson
Janet T ravis-Davis
Ah-Lirn Tsai
Kishor Wasan
Brenda Whaley
Barbara Williams
Li-Hua Wong
Kendra Woods
Virginia Wray
Willy Wriggers
Pamela Yang
Edward Yeh
Mary Yehle
Dihua Yu
}ing-Ren Zhang
Wei Zhang
Leonard Zwelling

Project GRAD
Project Grad founder Mr. James Ketelson and his wif~ Kathryn (not shown),
along with representatives of The Favrot Fund, Mr. Lenoir Josey II, Lenoir Josey
Ill, and Mr. James Calaway listen to a student journal reading about the morning's
experiment of isolating DNA. For the past three years GSBS has been selected
to provide a two-week hands-on biomedical sciences seminar for Project Grad
participants. The Project Grad Seminars at the GSBS is directed by Dr. Tom
Goka, Assistant Dean of Outreach and Minority Affairs.
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Hello Everyone,
This is my favorite time of year, the end of the academic year and the most important event, Commencement is n ow
b ehind us! After all of the effort, sacrifice, placing other aspects of life on hold to focus on research and writing, let the
celebrations b egin! Once friends and family saw our GSBS graduates cross that ever important stage to the joy and
pride of their faculty mentors they somehow understand just how powerful the joumey has been. I love the pageantry, the
tradition and I stand ready to join the party. Over 50 students crossed the stage with 50+ more celebrating in spirit from
their various new postdoctoral, pharmaceutical and Nil I positions.
To celebrate both students and alumni the Steering Committee organized several activities. First, we welcomed the
2006-2007 graduates into the official ranks of the GSBS Alumni Association with a final Friday Aftemoon Club (on
Thursday, May 3). Later, in June, we continued the tradition set last year of a great West Coast Reunion by hosting the
first ever East Coast Alumni Re union on June 16 in Washington D. C. Thirty~ intrepid alumsjoumeyed to Georgetown
for a wonderful evening and GSBS update. Our annual alumni-sponsored Career Day for GSBS students took place later
in June with 12 alumni speakers showcasing their professional expertise and stellar careers in areas which our students
indicated the desire to learn more. Thank you especially to Alumni Stars Russell Broaddus, M.D., Ph.D. ( 1994); Randy
Evans, Ph.D. (2002); Deanna Leonard, Ph.D. (2002); Janci Chunn Lingsay, Ph.D. (2006); Milton Marshall, Ph.D. (1975);
Darren Woodside, Ph.D. ( 1998), David Wooten, Ph. D. ( 1998) and the Alumni Steering Committee.
I have had the privilege this year to have worked with a dedicated and innovative group of Alumni Steering Committee members: past presidents Joya Chandra, Ph.D. ( 1998) and Dorrie Lamb, Ph.D. ( 1980); vice president Ben Thomas,
Ph.D. (1973); Vicky Estrera, Ph.D. (200 1); Maureen Goode, Ph.D. ( 1985); Mustafa Ozen, Ph.D. (1999) and our newest
member Joy Marshall, Ph.D. (2003). These GSBS alumni have enthusiastically devoted their time to make the 20062007 academic year extraordinary.
One final note and celebration to consider, our Distinguished GSBS Alumna for 2007-2008 is Dr. Suzanne Fuqua
( 1982/Naso) noted for her pioneering work on hormonal resistance in breast cancer. The Alumni Reunion in llouston is
scheduled for the evening of Friday, October 19 so plan now to celebrate with me.
Cheers,

'i~d.-A... 'V. t0oc&:, ,.P~. D.
Kendra Woods, Ph.D. (1995)
GSBS Alumni Association President
2006-2007
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